Physician profile
Lindsey Aurora
NPI 1003200056
$13,147.52
in general payments reported to CMS, 2019-2025
15 companies · $475 in 2025
The $475 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $317 · 2020: $298 · 2021: $789 · 2022: $8,514 · 2023: $1,501 · 2024: $1,254 · 2025: $475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,179 · Travel and Lodging: $1,051.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,178.76 |
| Travel and Lodging | $1,051.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $11,339.98 | 2019-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Abiomed | $765.08 | 2021-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $167.20 | 2020-2022 | |
| Livanova USA, INC. | $133.44 | 2023 | Lifesparc |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2022 | |
| Amgen INC. | $104.43 | 2019 | |
| Bard Peripheral Vascular, INC. | $104.21 | 2021 | |
| Cardiovascular Systems INC. | $95.52 | 2021 | |
| Procyrion, INC. | $81.27 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $80.59 | 2025 | |
| Teleflex LLC | $65.97 | 2022 | |
| Kestra Medical Technology Services, INC. | $27.84 | 2025 | Assure Wcd |
| Edwards Lifesciences Corporation | $23.19 | 2021 | |
| Novo Nordisk INC | $18.14 | 2023 | Ozempic |
| Medtronic, INC. | $15.66 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Aurora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.